Compare Rafael Holdings, Inc. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.01%
0%
-6.01%
6 Months
-26.95%
0%
-26.95%
1 Year
-37.82%
0%
-37.82%
2 Years
-33.83%
0%
-33.83%
3 Years
-42.45%
0%
-42.45%
4 Years
-66.91%
0%
-66.91%
5 Years
-95.58%
0%
-95.58%
Rafael Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-32.13%
EBIT Growth (5y)
-27.10%
EBIT to Interest (avg)
-24.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
9.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.26%
ROCE (avg)
0
ROE (avg)
5.94%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.39
EV to EBIT
-3.46
EV to EBITDA
-3.54
EV to Capital Employed
2.15
EV to Sales
50.44
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
-62.16%
ROE (Latest)
31.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Oct 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 8 Schemes (3.63%)
Foreign Institutions
Held by 12 Foreign Institutions (0.31%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ
Apr'25
Jan'25
Change(%)
Net Sales
0.40
0.10
300.00%
Operating Profit (PBDIT) excl Other Income
-5.90
-3.50
-68.57%
Interest
0.20
0.20
Exceptional Items
-1.00
-2.00
50.00%
Consolidate Net Profit
-4.10
-5.30
22.64%
Operating Profit Margin (Excl OI)
-16,334.30%
-46,610.40%
3,027.61%
USD in Million.
Net Sales
QoQ Growth in quarter ended Apr 2025 is 300.00% vs 0.00% in Jan 2025
Consolidated Net Profit
QoQ Growth in quarter ended Apr 2025 is 22.64% vs 42.39% in Jan 2025
Annual Results Snapshot (Consolidated) - Jul'24
Jul'24
Jul'23
Change(%)
Net Sales
0.60
0.30
100.00%
Operating Profit (PBDIT) excl Other Income
-12.50
-15.00
16.67%
Interest
0.20
0.00
Exceptional Items
-58.90
2.60
-2,365.38%
Consolidate Net Profit
-65.00
-8.70
-647.13%
Operating Profit Margin (Excl OI)
-20,040.80%
-53,917.60%
3,387.68%
USD in Million.
Net Sales
YoY Growth in year ended Jul 2024 is 100.00% vs -25.00% in Jul 2023
Consolidated Net Profit
YoY Growth in year ended Jul 2024 is -647.13% vs 93.81% in Jul 2023
About Rafael Holdings, Inc. 
Rafael Holdings, Inc.
Realty
Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company. The Company is focused on developing and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. It also owns interests in certain commercial real estate assets. The Company conducts business as two operating segments, Pharmaceuticals and Real Estate.
Company Coordinates 
Company Details
520 Broad St , NEWARK NJ : 07102-3121
Registrar Details






